Alveolar epithelium down-modulates endotoxin - But not tumor necrosis factor alpha-induced activation of endothelium and selectively inhibits neutrophil transendothelial migration

Experimental Lung Research

Volumn 34, Issue 7, 2008, Pages 425-453

  Weppler, Amy ^a   Issekutz, Andrew C ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Alveolus; Inflammation; Leukocyte; Lung; Recruitment

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 8; NITRIC OXIDE; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL FUNCTION; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; LUNG ENDOTHELIUM; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-8; LEUKOCYTE ROLLING; LIPOPOLYSACCHARIDES; NEUTROPHILS; PULMONARY ALVEOLI; RECOMBINANT PROTEINS; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION; TIME FACTORS; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 50049111679     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140802130105     Document Type: Article

References (75)

1. Lantz RC, Birch K, Hinton DE, Burrell R: Morphometric changes of the lung induced by inhaled bacterial endotoxin. Exp Mol Pathol. 1985;43:305-320.
2. Jagielo PJ, Thorne PS, Watt JL, Frees KL, Quinn TJ, Schwartz DA: Grain dust and endotoxin inhalation challenges produce similar inflammatory responses in normal subjects. Chest. 1996;110:263-270.
3. Schwartz DA, Thorne PS, Jagielo PJ, White GE, Bleuer SA, Frees KL: Endotoxin responsiveness and grain dust-induced inflammation in the lower respiratory tract. Am J Physiol. 1994;267:L609-L617.
4. Reynolds SJ, Milton DK, Heederik D, Thorne PS, Donham KJ, Croteau EA, Kelly KM, Douwes J, Lewis D, Whitmer M, Connaughton I, Koch S, Malmberg P, Larsson BM, Deddens J, Saraf A, Larsson L: Interlaboratory evaluation of endotoxin analyses in agricultural dusts - comparison of LAL assay and mass spectrometry. J Environ Monit. 2005;7:1371-1377.
5. Simpson JC, Niven RM, Pickering CA, Oldham LA, Fletcher AM, Francis HC: Comparative personal exposures to organic dusts and endotoxin. Ann Occup Hyg. 1999;43:107-115.
6. Brogden KA, Cutlip RC, Lehmkuhl HD: Response of sheep after localized deposition of lipopolysaccharide in the lung. Exp Lung Res. 1984;7:123-132.
7. Sethi S, Maloney J, Grove L, Wrona C, Berenson CS: Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173:991-998.
8. Chen HI, Kao SJ, Wang D, Lee RP, Su CF: Acute respiratory distress syndrome. J Biomed Sci. 2003;10:588-592.
9. Abraham E: Neutrophils and acute lung injury. Crit Care Med. 2003;31:S195-S199.
10. Lin WJ, Yeh WC: Implication of Toll-like receptor and tumor necrosis factor alpha signaling in septic shock. Shock. 2005;24:206-209.
11. Pugin J, Schurer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS: Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA. 1993;90:2744-2748.
12. Hollingsworth JW, Chen BJ, Brass DM, Berman K, Gunn MD, Cook DN, Schwartz DA: The critical role of hematopoietic cells in lipopolysaccharide-induced airway inflammation. Am J Respir Crit Care Med. 2005;171:806-813.
13. Armstrong L, Medford AR, Uppington KM, Robertson J, Witherden IR, Tetley TD, Millar AB: Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells. Am J Respir Cell Mol Biol. 2004;31:241-245.
14. Andonegui G, Bonder CS, Green F, Mullaly SC, Zbytnuik L, Raharjo E, Kubes P: Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs. J Clin Invest. 2003;111:1011-1020.
15. Yamamoto T, Kajikawa O, Martin TR, Sharar SR, Harlan JM, Winn RK: The role of leukocyte emigration and IL-8 on the development of lipopolysaccharide- induced lung injury in rabbits. J Immunol. 1998;161:5704-5709.
16. Tang WW, Yi ES, Remick DG, Wittwer A, Yin S, Qi M, Ulich TR: Intratracheal injection of endotoxin and cytokines. IX. Contribution of CD11a/ICAM-1 to neutrophil emigration. Am J Physiol. 1995;269:L653-L659.
17. Issekutz AC, Issekutz TB: Quantitation and kinetics of blood monocyte migration to acute inflammatory reactions, and IL-1 alpha, tumor necrosis factor-alpha, and IFN-gamma. J Immunol. 1993;151:2105-2115.
18. Cybulsky MI, McComb DJ, Movat HZ: Neutrophil leukocyte emigration induced by endotoxin. Mediator roles of interleukin 1 and tumor necrosis factor alpha 1. J Immunol. 1988;140:3144-3149.
19. Fakler CR, Wu B, McMicken HW, Geske RS, Welty SE: Molecular mechanisms of lipopolysaccharide induced ICAM-1 expression in A549 cells. Inflamm Res. 2000;49:63-72.
20. Pechkovsky DV, Zissel G, Ziegenhagen MW, Einhaus M, Taube C, Rabe KF, Magnussen H, Papadopoulos T, Schlaak M, Muller-Quernheim J: Effect of proinflammatory cytokines on interleukin-8 mRNA expression and protein production by isolated human alveolar epithelial cells type II in primary culture. Eur Cytokine Netw. 2000;11:618-625.
21. Koyama S, Sato E, Nomura H, Kubo K, Miura M, Yamashita T, Nagai S, Izumi T: The potential of various lipopolysaccharides to release IL-8 and G-CSF. Am J Physiol Lung Cell Mol Physiol. 2000;278:L658-L666.
22. MacRedmond R, Greene C, Taggart CC, McElvaney N, O'Neill S: Respiratory epithelial cells require Toll-like receptor 4 for induction of human beta-defensin 2 by lipopolysaccharide. Respir Res. 2005;6:116.
23. Jia HP, Kline JN, Penisten A, Apicella MA, Gioannini TL, Weiss J, McCray PB Jr: Endotoxin responsiveness of human airway epithelia is limited by low expression of MD-2. Am J Physiol Lung Cell Mol Physiol. 2004;287:L428-L437.
24. Haddad JJ: Recombinant TNF-alpha mediated regulation of the I kappa B-alpha/NF-kappa B signaling pathway: evidence for the enhancement of pro- and anti-inflammatory cytokines in alveolar epithelial cells. Cytokine. 2002;17:301-310.
25. Kwong KY, Literat A, Zhu NL, Huang HH, Li C, Jones CA, Minoo P: Expression of transforming growth factor beta (TGF-beta1) in human epithelial alveolar cells: a pro-inflammatory mediator independent pathway. Life Sci. 2004;74:2941-2957.
26. Kanj RS, Kang JL, Castranova V: Interaction between primary alveolar macrophages and primary alveolar type II cells under basal conditions and after lipopolysaccharide or quartz exposure. J Toxicol Environ Health A. 2006;69:1097-1116.
27. Rivas-Santiago B, Schwander SK, Sarabia C, Diamond G, Klein-Patel ME, Hernandez-Pando R, Ellner JJ, Sada E: Human β-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells. Infect Immun. 2005;73:4505-4511.
28. Bals R, Wang X, Zasloff M, Wilson JM: The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci USA. 1998;95:9541-9546.
29. Weppler A, Rowter D, Hermanns I, Kirkpatrick CJ, Issekutz AC: Modulation of endotoxin-induced neutrophil transendothelial migration by alveolar epithelium in a defined bilayer model. Exp Lung Res. 2006;32:455-482.
30. Kornbluth RS, Edgington TS: Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin. J Immunol. 1986;137:2585-2591.
31. de Azavedo JC, Drumm A, Jupin C, Parant M, Alouf JE, Arbuthnott JP: Induction of tumour necrosis factor by staphylococcal toxic shock toxin 1. FEMS Microbiol Immunol. 1988;1:69-74.
32. Djeu JY, Blanchard DK, Richards AL, Friedman H: Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. J Immunol. 1988;141:4047-4052.
33. Nedwin GE, Svedersky LP, Bringman TS, Palladino MA Jr, Goeddel DV: Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta. J Immunol. 1985;135:2492-2497.
34. Luscinskas FW, Cybulsky MI, Kiely JM, Peckins CS, Davis VM, Gimbrone MA Jr: Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1. J Immunol. 1991;146:1617-1625.
35. Ley K: Integration of inflammatory signals by rolling neutrophils. Immunol Rev. 2002;186:8-18.
36. Magder S, Neculcea J, Neculcea V, Sladek R: Lipopolysaccharide and TNF-alpha produce very similar changes in gene expression in human endothelial cells. J Vasc Res. 2006;43:447-461.
37. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973;52:2745-2756.
38. Issekutz AC, Rowter D, Springer TA: Role of ICAM-1 and ICAM-2 and alternate CD11/CD18 ligands in neutrophil transendothelial migration. J Leukoc Biol. 1999;65:117-126.
39. Drake WT, Issekutz AC: A role for alpha-thrombin in polymorphonuclear leukocyte recruitment during inflammation. Semin Thromb Hemost. 1992;18:333-340.
40. Liu Y, Merlin D, Burst SL, Pochet M, Madara JL, Parkos CA: The role of CD47 in neutrophil transmigration. Increased rate of migration correlates with increased cell surface expression of CD47. J Biol Chem. 2001;276:40156-40166.
41. Abbassi O, Kishimoto TK, McIntire LV, Smith CW: Neutrophil adhesion to endothelial cells. Blood Cells. 1993;19:245-259; discussion 259-260.
42. Luscinskas FW, Ding H, Lichtman AH: P-selectin and vascular cell adhesion molecule 1 mediate rolling and arrest, respectively, of CD4+ T lymphocytes on tumor necrosis factor alpha-activated vascular endothelium under flow. J Exp Med. 1995;181:1179-1186.
43. Jonjic N, Peri G, Bernasconi S, Sciacca FL, Colotta F, Pelicci P, Lanfrancone L, Mantovani A: Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med. 1992;176:1165-1174.
44. Feuerhake F, Fuchsl G, Bals R, Welsch U: Expression of inducible cell adhesion molecules in the normal human lung: immunohistochemical study of their distribution in pulmonary blood vessels. Histochem Cell Biol. 1998;110:387-394.
45. Beck-Schimmer B, Schimmer RC, Warner RL, Schmal H, Nordblom G, Flory CM, Lesch ME, Friedl HP, Schrier DJ, Ward PA: Expression of lung vascular and airway ICAM-1 after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol. 1997;17:344-352.
46. Standiford TJ, Kunkel SL, Basha MA, Chensue SW, Lynch JP 3rd, Toews GB, Westwick J, Strieter RM: Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J Clin Invest. 1990;86:1945-1953.
47. De Beaux AC, Maingay JP, Ross JA, Fearon KC, Carter DC: Interleukin-4 and interleukin-10 increase endotoxin-stimulated human umbilical vein endothelial cell interleukin-8 release. J Interferon Cytokine Res. 1995;15:441-445.
48. Inoue G: Effect of interleukin-10 (IL-10) on experimental LPS-induced acute lung injury. J Infect Chemother. 2000;6:51-60.
49. Lo CJ, Fu M, Cryer HG: Interleukin 10 inhibits alveolar macrophage production of inflammatory mediators involved in adult respiratory distress syndrome. J Surg Res. 1998;79:179-184.
50. Larsson AK, Back M, Hjoberg J, Dahlen SE: Inhibition of nitric-oxide synthase enhances antigen-induced contractions and increases release of cysteinyl-leukotrienes in guinea pig lung parenchyma: nitric oxide as a protective factor. J Pharmacol Exp Ther. 2005;315:458-465.
51. Ameredes BT, Sethi JM, Liu HL, Choi AM, Calhoun WJ: Enhanced nitric oxide production associated with airway hyporesponsiveness in the absence of IL-10. Am J Physiol Lung Cell Mol Physiol. 2005;288:L868-L873.
52. Dal Secco D, Moreira AP, Freitas A, Silva JS, Rossi MA, Ferreira SH, Cunha FQ: Nitric oxide inhibits neutrophil migration by a mechanism dependent on ICAM-1: role of soluble guanylate cyclase. Nitric Oxide. 2006;15:77-86.
53. Guo FH, Erzurum SC: Characterization of inducible nitric oxide synthase expression in human airway epithelium. Environ Health Perspect. 1998;106(Suppl 5):1119-1124.
54. Watkins DN, Peroni DJ, Basclain KA, Garlepp MJ, Thompson PJ: Expression and activity of nitric oxide synthases in human airway epithelium. Am J Respir Cell Mol Biol. 1997;16:629-639.
55. Roy S, Sharma S, Sharma M, Aggarwal R, Bose M: Induction of nitric oxide release from the human alveolar epithelial cell line A549: an in vitro correlate of innate immune response to Mycobacterium tuberculosis. Immunology. 2004;112:471-480.
56. Strieter RM, Kunkel SL, Showell HJ, Remick DG, Phan SH, Ward PA, Marks RM: Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. Science. 1989;243:1467-1469.
57. Furie MB, Burns MJ, Tancinco MC, Benjamin CD, Lobb RR: E-selectin (endothelial-leukocyte adhesion molecule-1) is not required for the migration of neutrophils across IL-1-stimulated endothelium in vitro. J Immunol. 1992;148:2395-2404.
58. Mulligan MS, Varani J, Dame MK, Lane CL, Smith CW, Anderson DC, Ward PA: Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats. J Clin Invest. 1991;88:1396-1406.
59. Gundel RH, Wegner CD, Torcellini CA, Clarke CC, Haynes N, Rothlein R, Smith CW, Letts LG: Endothelial leukocyte adhesion molecule-1 mediates antigen-induced acute airway inflammation and late-phase airway obstruction in monkeys. J Clin Invest. 1991;88:1407-1411.
60. Smith WB, Gamble JR, Clark-Lewis I, Vadas MA: Interleukin-8 induces neutrophil transendothelial migration. Immunology. 1991;72:65-72.
61. Moser B, Willimann K: Chemokines: role in inflammation and immune surveillance. Ann Rheum Dis. 2004;63 Suppl 2:ii84-ii89.
62. Wilkinson PC: How do leucocytes perceive chemical gradients? FEMS Microbiol Immunol. 1990;2:303-311.
63. Yang J, Zhu J, Sun D, Ding A: Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function. Biochim Biophys Acta. 2005;1745:310-317.
64. Jin FY, Nathan C, Radzioch D, Ding A: Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell. 1997;88:417-426.
65. Taggart CC, Cryan SA, Weldon S, Gibbons A, Greene CM, Kelly E, Low TB, O'Neill SJ, McElvaney NG: Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding. J Exp Med. 2005;202:1659-1668.
66. Lentsch AB, Jordan JA, Czermak BJ, Diehl KM, Younkin EM, Sarma V, Ward PA: Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation. Am J Pathol. 1999;154:239-247.
67. Sano C, Shimizu T, Sato K, Kawauchi H, Tomioka H: Effects of secretory leucocyte protease inhibitor on the production of the anti-inflammatory cytokines, IL-10 and transforming growth factor-beta (TGF-beta), by lipopolysaccharide-stimulated macrophages. Clin Exp Immunol. 2000;121:77-85.
68. Ding A, Thieblemont N, Zhu J, Jin F, Zhang J, Wright S: Secretory leukocyte protease inhibitor interferes with uptake of lipopolysaccharide by macrophages. Infect Immun. 1999;67:4485-4489.
69. Hollander C, Nystrom M, Janciauskiene S, Westin U: Human mast cells decrease SLPI levels in type II-like alveolar cell model, in vitro. Cancer Cell Int. 2003;3:14.
70. Henriksen PA, Hitt M, Xing Z, Wang J, Haslett C, Riemersma RA, Webb DJ, Kotelevtsev YV, Sallenave JM: Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-kappa B-dependent inflammatory responses of human endothelial cells and macrophages to atherogenic stimuli. J Immunol. 2004;172:4535-4544.
71. Scott MG, Davidson DJ, Gold MR, Bowdish D, Hancock RE: The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol. 2002;169:3883-3891.
72. Stamme C, Muller M, Hamann L, Gutsmann T, Seydel U: Surfactant protein a inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide-binding protein. Am J Respir Cell Mol Biol. 2002;27:353-360.
73. Ulich TR, Fann MJ, Patterson PH, Williams JH, Samal B, Del Castillo J, Yin S, Guo K, Remick DG: Intratracheal injection of LPS and cytokines. V. LPS induces expression of LIF and LIF inhibits acute inflammation. Am J Physiol. 1994;267:L442-L446.
74. Delayre-Orthez C, Becker J, Guenon I, Lagente V, Auwerx J, Frossard N, Pons F: PPARalpha downregulates airway inflammation induced by lipopolysaccharide in the mouse. Respir Res. 2005;6:91.
75. Ruiz-Torres MP, Perez-Rivero G, Rodriguez-Puyol M, Rodriguez-Puyol D, Diez-Marques ML: The leukocyte-endothelial cell interactions are modulated by extracellular matrix proteins. Cell Physiol Biochem. 2006;17:221-232.